Lyfe Capital, Sequoia Join $23M Series A+ Round In Burning Rock Biotech

Guangzhou-based cancer diagnostic start-up Burning Rock Biotech has completed RMB150 million (US$23 million) series A+ round of funding from Lyfe Capital, Sequoia Capital and Legend Star, according to a company announcement. The company says it will use the proceeds on its research and development efforts, as well as developing new products to meet patient demand.

Cancer Screening Firm Anpac Completes Series A Round

Sacramento, California-based cancer screening biotech firm Anpac Bio-Medical Science Co., Ltd. has completed series A round of funding from Shanghai Zhangjiang Science & Technology Investment Corporation, according to a company announcement. The round is worth several million U.S. dollars, says the statement.